Generic Name: Omalizumab
Brand Name: Xolair
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Therapeutic Area: Asthma, severe persistent
Indications: Asthma, severe persistent
Submission Type: Initial
Project Status: Cancelled
CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Omalizumab
Brand Name: Xolair
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Therapeutic Area: Asthma, severe persistent
Indications: Asthma, severe persistent
Submission Type: Initial
Project Status: Cancelled